Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 April 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
The Wolves
The Wolves is a play which does not conform to mainstream female stereotypes.

It is the perfect father and daughter team - Gerben Kamper, well-known actor and former drama lecturer at the University of the Free State (UFS), and his daughter Marijda Kamper, a current Drama and Theatre Arts staff member at UFS who have taken on the task of directing and producing the play, The Wolves by Sarah DeLappe.

It was a finalist for the Pulitzer Prize for Drama in 2017. “The text is regarded very highly, most drama texts do not normally get such recognition,” said Marijda.  

The play will be performed at the Scaena on the Bloemfontein Campus from Wednesday 10 April 2019.

“This play provides an excellent acting opportunity for our students. It is also nice to get a play which accommodates so many female actors,” said Marijda. Because this play digs deep within the daily struggles of being a girl, it is a sort of homage to the current #MeToo movement. It is a play about the coming-of-age for nine girls and centres in a non-stereotypical manner on the experiences, attitudes, anxiety and the adolescent hormonal changes of girls in the contemporary world. 

“It is very exciting to be back at the department. Especially with this play. It is very different from the usual plays we get. As it is set on an indoor soccer field, it is quite a different ballgame. This play provides the opportunity to focus on all the facets of acting,” said Gerben. 

The play has six scenes and takes place just before the start of a soccer match. “So the girls are busy with warm-up exercises just minutes before the whistle,” said Marijda. “The soccer unit at KovsieSport helped us a lot. They arranged a real soccer coach to assist us, and for two weeks she trained our girls like real soccer players.”



News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept